SE461854B - Acetylerytromycinstearat och terapeutisk komposition innehaallande det - Google Patents

Acetylerytromycinstearat och terapeutisk komposition innehaallande det

Info

Publication number
SE461854B
SE461854B SE8406671A SE8406671A SE461854B SE 461854 B SE461854 B SE 461854B SE 8406671 A SE8406671 A SE 8406671A SE 8406671 A SE8406671 A SE 8406671A SE 461854 B SE461854 B SE 461854B
Authority
SE
Sweden
Prior art keywords
stearate
erythromycin
acetylerythromycin
tablets
ethyl acetate
Prior art date
Application number
SE8406671A
Other languages
English (en)
Swedish (sv)
Other versions
SE8406671D0 (sv
SE8406671L (sv
Inventor
M L A Marvola
E V Marttila
J A Uotila
A K Pippuri
P J Kairisalo
E J Honkanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of SE8406671D0 publication Critical patent/SE8406671D0/xx
Publication of SE8406671L publication Critical patent/SE8406671L/xx
Publication of SE461854B publication Critical patent/SE461854B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
SE8406671A 1984-01-06 1984-12-28 Acetylerytromycinstearat och terapeutisk komposition innehaallande det SE461854B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (3)

Publication Number Publication Date
SE8406671D0 SE8406671D0 (sv) 1984-12-28
SE8406671L SE8406671L (sv) 1985-07-07
SE461854B true SE461854B (sv) 1990-04-02

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8406671A SE461854B (sv) 1984-01-06 1984-12-28 Acetylerytromycinstearat och terapeutisk komposition innehaallande det

Country Status (38)

Country Link
US (1) US4599326A (ja)
JP (1) JPS60158197A (ja)
KR (1) KR900006237B1 (ja)
AT (1) AT386414B (ja)
AU (1) AU565688B2 (ja)
BE (1) BE901411A (ja)
BG (1) BG43189A3 (ja)
CA (1) CA1224461A (ja)
CH (1) CH666275A5 (ja)
CS (1) CS247191B2 (ja)
CY (1) CY1462A (ja)
DE (1) DE3500179A1 (ja)
DK (1) DK149776C (ja)
ES (1) ES8605818A1 (ja)
FI (1) FI77249C (ja)
FR (1) FR2557878B1 (ja)
GB (1) GB2152502B (ja)
HK (1) HK11590A (ja)
HU (1) HU196221B (ja)
IE (1) IE57967B1 (ja)
IL (1) IL73885A (ja)
IS (1) IS2968A7 (ja)
IT (1) IT1184304B (ja)
KE (1) KE3841A (ja)
LU (1) LU85721A1 (ja)
MA (1) MA20316A1 (ja)
MX (1) MX156277A (ja)
NL (1) NL8403979A (ja)
NO (1) NO160263C (ja)
NZ (1) NZ210606A (ja)
PH (1) PH22471A (ja)
PL (1) PL144349B1 (ja)
PT (1) PT79777B (ja)
RO (1) RO91262B (ja)
SE (1) SE461854B (ja)
SU (1) SU1410866A3 (ja)
YU (1) YU44485B (ja)
ZA (1) ZA8410143B (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US7771707B2 (en) 2004-06-12 2010-08-10 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
JP4694207B2 (ja) * 2002-07-05 2011-06-08 コルジウム ファーマシューティカル， インコーポレイテッド オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
AU2004285531A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for enhanced absorption of metformin
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
CA2743725A1 (en) 2006-06-23 2007-12-27 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2012158964A2 (en) 2011-05-18 2012-11-22 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals for osteoporosis
EP2922877B1 (en) 2012-11-20 2018-09-05 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
JP6525456B2 (ja) 2012-11-20 2019-06-05 メデリス ダイアビーティーズ，エルエルシー インスリン抵抗性のための改善されたペプチド製剤
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
DK3155017T3 (da) 2014-05-28 2024-04-15 Mederis Diabetes Llc Forbedrede lægemidler til insulinresistens
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
WO2018213751A1 (en) 2017-05-19 2018-11-22 Lunella Biotech, Inc. Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
WO2019108729A1 (en) 2017-12-01 2019-06-06 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
HRP20221525T1 (hr) 2018-02-06 2023-03-03 Aegis Therapeutics, Llc Intranazalne formulacije epinefrina i postupci za liječenje bolesti
WO2020131704A1 (en) * 2018-12-17 2020-06-25 Lunella Biotech, Inc. Triple combination therapies for anti-aging
PE20211551A1 (es) * 2018-12-17 2021-08-16 Lunella Biotech Inc Terapias de combinacion triple para fijar como objetivo mitocondrias y aniquilar celulas madre cancerosas
EA202091615A1 (ru) 2018-12-21 2021-03-05 Аегис Терапьютикс, Ллс Интраназальные составы на основе эпинефрина и способы лечения заболевания

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
FR2557878A1 (fr) 1985-07-12
ES539349A0 (es) 1986-04-01
DE3500179C2 (ja) 1989-08-24
FI850023A0 (fi) 1985-01-03
GB2152502B (en) 1987-10-07
SE8406671D0 (sv) 1984-12-28
PL251457A1 (en) 1985-11-05
JPH029040B2 (ja) 1990-02-28
BE901411A (fr) 1985-04-16
NO160263B (no) 1988-12-19
CH666275A5 (de) 1988-07-15
IT1184304B (it) 1987-10-28
CS247191B2 (en) 1986-12-18
KE3841A (en) 1989-04-07
GB2152502A (en) 1985-08-07
FI77249B (fi) 1988-10-31
CA1224461A (en) 1987-07-21
PH22471A (en) 1988-09-12
KR850005452A (ko) 1985-08-26
AT386414B (de) 1988-08-25
SU1410866A3 (ru) 1988-07-15
IE57967B1 (en) 1993-06-02
ZA8410143B (en) 1985-08-28
PL144349B1 (en) 1988-05-31
MA20316A1 (fr) 1985-10-01
IS2968A7 (is) 1985-04-03
DK5884A (da) 1985-07-07
RO91262B (ro) 1987-07-01
SE8406671L (sv) 1985-07-07
BG43189A3 (en) 1988-04-15
AU3705984A (en) 1985-07-11
KR900006237B1 (ko) 1990-08-27
RO91262A (ro) 1987-06-30
DK5884D0 (da) 1984-01-06
LU85721A1 (fr) 1985-07-24
YU44485B (en) 1990-08-31
DK149776C (da) 1987-04-21
ATA985A (de) 1988-01-15
GB8432368D0 (en) 1985-02-06
FR2557878B1 (fr) 1988-01-15
IL73885A (en) 1988-10-31
JPS60158197A (ja) 1985-08-19
IE850022L (en) 1985-07-06
US4599326A (en) 1986-07-08
DE3500179A1 (de) 1985-07-18
HU196221B (en) 1988-10-28
YU2085A (en) 1987-12-31
PT79777B (en) 1986-10-21
HK11590A (en) 1990-02-23
NZ210606A (en) 1987-08-31
NO850007L (no) 1985-07-08
AU565688B2 (en) 1987-09-24
FI77249C (fi) 1989-02-10
DK149776B (da) 1986-09-29
PT79777A (en) 1985-01-01
ES8605818A1 (es) 1986-04-01
IL73885A0 (en) 1985-03-31
NL8403979A (nl) 1985-08-01
NO160263C (no) 1989-03-29
FI850023L (fi) 1985-07-07
CY1462A (en) 1989-07-21
MX156277A (es) 1988-08-04
IT8519012A0 (it) 1985-01-04
HUT37628A (en) 1986-01-23

Similar Documents

Publication Publication Date Title
SE461854B (sv) Acetylerytromycinstearat och terapeutisk komposition innehaallande det
RU2478643C2 (ru) Макроциклические полиморфы, композиции, содержащие такие полиморфы, и способы их применения и получения
JPH0784424B2 (ja) チロシン誘導体及びその用途
EA021683B1 (ru) Производные деоксиактагардина в
KR101388061B1 (ko) 멧돼지과 동물 또는 양(羊)용 항 구제역 바이러스제 및 멧돼지과 동물 또는 양의 구제역의 예방 또는 치료방법
JPS608000B2 (ja) アミノフエニル誘導体及び該誘導体を含有する生理活性剤
RU2454230C2 (ru) Лечение и профилактика заболеваний и инфекций свиней и домашней птицы
JPH0778021B2 (ja) 下痢症ウイルス感染阻害剤
CN111233831A (zh) 常山铜琥珀酸单酯及其制备方法与用途
GB1577545A (en) Treatment of swine dysenter
CA1173029A (en) Acylated laidlomycin derivatives
US4686207A (en) Erythromycin A 11,12-carbonates and method of use
CN1812796B (zh) 爱乐新用于治疗由厌氧性肠道螺旋体或鼻腔鸟杆菌引起的疾病
KR850000966B1 (ko) Dmt의 c-23-변형 유도체의 제조방법
JPH0586374B2 (ja)
US3013942A (en) Therapeutic erythromycin ester compositions
JPS60218321A (ja) 消化管収縮運動促進剤
US4205081A (en) Composition and method for preventing or treating swine dysentery
JPH07179348A (ja) スクロースアシル体を有効成分とする脳機能改善剤
JP3406334B2 (ja) チロシン特異的リン酸化酵素阻害剤及び制癌剤
JPS6046087B2 (ja) コクシジウム症予防治療剤
JPS5950318B2 (ja) 新規抗生物質ｓｙ−２物質
PL91696B1 (ja)
JPS59161386A (ja) セフアロスポリン誘導体及び該誘導体を含有する医薬
CS196263B2 (cs) Krmná směs pro zvířata

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8406671-1

Effective date: 19940710

Format of ref document f/p: F